Survivorship Programs Improve Quality of Life, Satisfaction in Prostate Cancer

Share this content:

the Cancer Therapy Advisor take:

Men with prostate cancer managed in a survivorship program report higher quality of life (QOL) and satisfaction than those who were managed by routine care, according to an article published online in Cancer.

In this study, patient-reported outcomes (PROs) such as QOL were integrated into a prostate cancer survivorship clinic and evaluated at 6 and 12 months. 

Participants included 235 men being surgically treated for prostate cancer using routine follow-up care and 102 men managed in the survivorship clinic with the integrated point-of-care QOL reporting after radical prostatectomy. 

Results showed that baseline QOL was comparable, but men in the survivorship groups had higher scores at 6 and 12 months than those following the routine care.  For example, male patients in the survivorship clinic reported higher sexual function than those in routine care (52.2 vs 33.6 at 1 year, P<0.05).

The study suggests that disease-specific survivorship clinics with integrated QOL reporting may generate better results than clinics with routine care following cancer therapy.

Radiotherapy plus temozolomide did not appear to significantly improve survival for anapestic astroc
Men with prostate cancer managed in a survivorship program report higher quality of life and satisfaction.
Integrating quality-of-life (QOL) outcomes into clinics may assist providers in identifying and responding to problems experienced by cancer survivors. To date, however, patient-reported outcomes (PROs) such as QOL are used infrequently to guide care.
READ FULL ARTICLE From Wiley Online Library

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs